BACKGROUND Diabetes and thyroiditis are closely related.They occur in combination and cause significant damage to the body.There is no clear treatment for type-2 diabetes mellitus(T2DM)with Hashimoto's thyroiditis...BACKGROUND Diabetes and thyroiditis are closely related.They occur in combination and cause significant damage to the body.There is no clear treatment for type-2 diabetes mellitus(T2DM)with Hashimoto's thyroiditis(HT).While single symptomatic drug treatment of the two diseases is less effective,combined drug treatment may improve efficacy.AIM To investigate the effect of a combination of vitamin D,selenium,and hypoglycemic agents in T2DM with HT.METHODS This retrospective study included 150 patients with T2DM and HT treated at The Central Hospital of Shaoyang from March 2020 to February 2023.Fifty patients were assigned to the control group,test group A,and test group B according to different treatment methods.The control group received low-iodine diet guidance and hypoglycemic drug treatment.Test group A received the control treatment plus vitamin D treatment.Test group B received the group A treatment plus selenium.Blood levels of markers of thyroid function[free T3(FT3),thyroid stimulating hormone(TSH),free T4(FT4)],autoantibodies[thyroid peroxidase antibody(TPOAB)and thyroid globulin antibody(TGAB)],blood lipid index[low-density lipoprotein cholesterol(LDL-C),total cholesterol(TC),triacylglycerol(TG)],blood glucose index[fasting blood glucose(FBG),and hemoglobin A1c(HbA1c)]were measured pre-treatment and 3 and 6 months after treatment.The relationships between serum 25-hydroxyvitamin D3[25(OH)D3]level and each of these indices were analyzed.RESULTS The levels of 25(OH)D3,FT3,FT4,and LDL-C increased in the order of the control group,test group A,and test group B(all P<0.05).The TPOAB,TGAB,TC,TG,FBG,HbA1c,and TSH levels increased in the order of test groups B,A,and the control group(all P<0.05).All the above indices were compared after 3 and 6 months of treatment.Pre-treatment,there was no divergence in serum 25(OH)D3 level,thyroid function-related indexes,autoantibodies level,blood glucose,and blood lipid index between the control group,test groups A and B(all P>0.05).The 25(OH)D3 levels in test groups A and B were negatively correlated with FT4 and TGAB(all P<0.05).CONCLUSION The combination drug treatment for T2DM with HT significantly improved thyroid function,autoantibody,and blood glucose and lipid levels.展开更多
目的:探究归脾汤加味联合醒脑开窍针法治疗非痴呆性血管认知障碍(VCIND)心脾不足证的疗效及部分作用机制。方法:选取天津中医药大学第一附属医院2017年5月至2018年10月收治的VCIND心脾不足证患者122例,随机分为归脾汤加味组(39例),针刺...目的:探究归脾汤加味联合醒脑开窍针法治疗非痴呆性血管认知障碍(VCIND)心脾不足证的疗效及部分作用机制。方法:选取天津中医药大学第一附属医院2017年5月至2018年10月收治的VCIND心脾不足证患者122例,随机分为归脾汤加味组(39例),针刺组(42例)和联合组(41例),3组患者均给予抗凝类药物及降脂类药物口服常规治疗;归脾汤加味组在常规治疗基础上给予归脾汤加味150 m L/次,2次/d口服;针刺组在常规治疗基础上采用醒脑开窍针法治疗,取水沟,内关(双侧),三阴交(双侧),四神聪,悬钟(双侧)及太溪(双侧),2次/d,每周治疗6 d;联合组在归脾汤加味组治疗基础上给予醒脑开窍针法治疗,3组患者均治疗8周。观察3组患者治疗前、治疗4,8周后蒙特利尔认知评估量表(MoCA量表,北京版)及日常生活能力(ADL)量表评分、中医症状积分结果及临床疗效;采用酶联免疫吸附测定法检测患者不同治疗时间血清降钙素基因相关肽(CGRP)及视锥蛋白样蛋白-1(VILIP-1)含量。结果:与归脾汤加味组及针刺组治疗4,8周比较,联合组患者MoCA,ADL及中医证候评分降低,且治疗4,8周总有效率均明显升高;血清CGRP含量升高,VILIP-1含量降低。结论:归脾汤加味联合醒脑开窍针法治疗VCIND心脾不足证有明确疗效,其机制可能与扩张血管、改善脑部血液供给,减少神经元损伤有关。展开更多
基金Supported by Science and Technology Plan Project of Shaoyang City,No.2022GX4139.
文摘BACKGROUND Diabetes and thyroiditis are closely related.They occur in combination and cause significant damage to the body.There is no clear treatment for type-2 diabetes mellitus(T2DM)with Hashimoto's thyroiditis(HT).While single symptomatic drug treatment of the two diseases is less effective,combined drug treatment may improve efficacy.AIM To investigate the effect of a combination of vitamin D,selenium,and hypoglycemic agents in T2DM with HT.METHODS This retrospective study included 150 patients with T2DM and HT treated at The Central Hospital of Shaoyang from March 2020 to February 2023.Fifty patients were assigned to the control group,test group A,and test group B according to different treatment methods.The control group received low-iodine diet guidance and hypoglycemic drug treatment.Test group A received the control treatment plus vitamin D treatment.Test group B received the group A treatment plus selenium.Blood levels of markers of thyroid function[free T3(FT3),thyroid stimulating hormone(TSH),free T4(FT4)],autoantibodies[thyroid peroxidase antibody(TPOAB)and thyroid globulin antibody(TGAB)],blood lipid index[low-density lipoprotein cholesterol(LDL-C),total cholesterol(TC),triacylglycerol(TG)],blood glucose index[fasting blood glucose(FBG),and hemoglobin A1c(HbA1c)]were measured pre-treatment and 3 and 6 months after treatment.The relationships between serum 25-hydroxyvitamin D3[25(OH)D3]level and each of these indices were analyzed.RESULTS The levels of 25(OH)D3,FT3,FT4,and LDL-C increased in the order of the control group,test group A,and test group B(all P<0.05).The TPOAB,TGAB,TC,TG,FBG,HbA1c,and TSH levels increased in the order of test groups B,A,and the control group(all P<0.05).All the above indices were compared after 3 and 6 months of treatment.Pre-treatment,there was no divergence in serum 25(OH)D3 level,thyroid function-related indexes,autoantibodies level,blood glucose,and blood lipid index between the control group,test groups A and B(all P>0.05).The 25(OH)D3 levels in test groups A and B were negatively correlated with FT4 and TGAB(all P<0.05).CONCLUSION The combination drug treatment for T2DM with HT significantly improved thyroid function,autoantibody,and blood glucose and lipid levels.
文摘目的:探究归脾汤加味联合醒脑开窍针法治疗非痴呆性血管认知障碍(VCIND)心脾不足证的疗效及部分作用机制。方法:选取天津中医药大学第一附属医院2017年5月至2018年10月收治的VCIND心脾不足证患者122例,随机分为归脾汤加味组(39例),针刺组(42例)和联合组(41例),3组患者均给予抗凝类药物及降脂类药物口服常规治疗;归脾汤加味组在常规治疗基础上给予归脾汤加味150 m L/次,2次/d口服;针刺组在常规治疗基础上采用醒脑开窍针法治疗,取水沟,内关(双侧),三阴交(双侧),四神聪,悬钟(双侧)及太溪(双侧),2次/d,每周治疗6 d;联合组在归脾汤加味组治疗基础上给予醒脑开窍针法治疗,3组患者均治疗8周。观察3组患者治疗前、治疗4,8周后蒙特利尔认知评估量表(MoCA量表,北京版)及日常生活能力(ADL)量表评分、中医症状积分结果及临床疗效;采用酶联免疫吸附测定法检测患者不同治疗时间血清降钙素基因相关肽(CGRP)及视锥蛋白样蛋白-1(VILIP-1)含量。结果:与归脾汤加味组及针刺组治疗4,8周比较,联合组患者MoCA,ADL及中医证候评分降低,且治疗4,8周总有效率均明显升高;血清CGRP含量升高,VILIP-1含量降低。结论:归脾汤加味联合醒脑开窍针法治疗VCIND心脾不足证有明确疗效,其机制可能与扩张血管、改善脑部血液供给,减少神经元损伤有关。